XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 38 filers reported holding XENON PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,911,081 | -11.2% | 55,945 | +0.1% | 0.00% | – |
Q2 2023 | $2,152,727 | +7.9% | 55,915 | +0.3% | 0.00% | – |
Q1 2023 | $1,994,397 | +91428.1% | 55,725 | +0.8% | 0.00% | – |
Q4 2022 | $2,179 | -99.9% | 55,285 | -10.6% | 0.00% | – |
Q3 2022 | $2,231,000 | +61.2% | 61,823 | +35.8% | 0.00% | – |
Q2 2022 | $1,384,000 | +60.6% | 45,516 | +61.4% | 0.00% | – |
Q1 2022 | $862,000 | -2.0% | 28,198 | 0.0% | 0.00% | – |
Q4 2021 | $880,000 | +166.7% | 28,198 | +30.2% | 0.00% | – |
Q3 2021 | $330,000 | -18.1% | 21,650 | 0.0% | 0.00% | – |
Q2 2021 | $403,000 | +17.2% | 21,650 | +12.5% | 0.00% | – |
Q1 2021 | $344,000 | +16.6% | 19,242 | 0.0% | 0.00% | – |
Q4 2020 | $295,000 | +38.5% | 19,242 | 0.0% | 0.00% | – |
Q3 2020 | $213,000 | -11.6% | 19,242 | 0.0% | 0.00% | – |
Q2 2020 | $241,000 | +10.6% | 19,242 | 0.0% | 0.00% | – |
Q1 2020 | $218,000 | -56.7% | 19,242 | -50.0% | 0.00% | – |
Q4 2019 | $504,000 | +191.3% | 38,484 | +100.0% | 0.00% | – |
Q3 2019 | $173,000 | -8.5% | 19,242 | 0.0% | 0.00% | – |
Q2 2019 | $189,000 | +32.2% | 19,242 | +36.6% | 0.00% | – |
Q1 2019 | $143,000 | -18.8% | 14,084 | -50.0% | 0.00% | – |
Q4 2018 | $176,000 | +329.3% | 28,168 | +171.2% | 0.00% | – |
Q1 2017 | $41,000 | -46.8% | 10,386 | +3.7% | 0.00% | – |
Q4 2016 | $77,000 | – | 10,020 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 1,594,932 | $48,518,000 | 10.26% |
GREAT POINT PARTNERS LLC | 1,104,334 | $33,594,000 | 8.06% |
ACUTA CAPITAL PARTNERS, LLC | 272,500 | $8,289,000 | 4.62% |
DAFNA Capital Management LLC | 438,623 | $13,343,000 | 3.64% |
Parkman Healthcare Partners LLC | 294,559 | $8,960,000 | 3.30% |
Avoro Capital Advisors LLC | 4,900,000 | $149,058,000 | 2.94% |
Nan Fung Group Holdings Ltd | 114,380 | $3,479,000 | 2.39% |
BVF INC/IL | 1,597,966 | $48,610,000 | 2.35% |
SILVERARC CAPITAL MANAGEMENT, LLC | 232,630 | $7,077,000 | 2.18% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 4,391,038 | $133,575,000 | 2.16% |